PT. Penta Valent Tbk (IDX:PEVE)

Market Cap	872.22B +66.9%
Revenue (ttm)	3.41T +18.4%
Net Income	59.85B +35.8%
EPS	34.35 +37.5%
Shares Out	1.77B
PE Ratio	14.38
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	64,000
Average Volume	156,625
Open	490.00
Previous Close	505.00
Day's Range	490.00 - 510.00
52-Week Range	260.00 - 740.00
Beta	0.20
RSI	40.78
Earnings Date	Apr 2, 2026

About PT. Penta Valent Tbk

PT. Penta Valent Tbk distributes pharmaceutical products, medical equipment, and consumer products in Indonesia. It operates through Pharmaceutical Products and Consumer Goods segments. The company offers prescription medicinal products; over the counter drug products; medical supporting equipment, such as blood pressure meters, body thermometers, and others; reaction materials, such as blood sugar tests, pregnancy tests, or rapid tests for Covid-19, drug tests, etc.; and food supplements comprising minerals and nutrients. It also provides prod...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1968
• Employees: 1,481
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: PEVE

Financial Performance

In 2024, PT. Penta Valent Tbk's revenue was 3.01 trillion, an increase of 21.25% compared to the previous year's 2.48 trillion. Earnings were 48.01 billion, an increase of 32.73%.